Canine discrimination of ovarian cancer through volatile organic compounds

• Published in: Talanta (Oxford) 2022-12, Vol.250, p.123729-123729, Article 123729
• Main Authors: Kane, S.A., Lee, Y.E., Essler, J.L., Mallikarjun, A., Preti, G., Plymouth, V.L., Verta, A., DeAngelo, A., Otto, C.M.
• Format: Article
• Language: English
• Subjects: Biomarkers; Detection dogs; MP-GC; Ovarian cancer; VOCs
• ISSN: 0039-9140; 1873-3573
• DOI: 10.1016/j.talanta.2022.123729

Ovarian cancer has a high mortality rate due to its unclear symptomology and the lack of precise early detection tools. If detected in the first stage, over 90% of patients reach remission. As such, developing a reliable method of early detection is crucial in reducing the mortality rate of the disease. One potential method would be to identify specific biomarkers that are unique to ovarian cancer, which could be detected using a blood test. While this can be done using gas chromatography – mass spectrometry (GC–MS), identifying these biomarkers is an enormous task. One way to expedite the process is to utilize trained scent detection canines. In this study, dogs who were previously trained to respond to positive blood samples from ovarian cancer patients were then tested on their ability to recognize samples prepared by micro-preparative gas chromatography (MP–GC) techniques. MP–GC employed a gradient-cooled glass tube connected to the GC outlet to collect GC eluents containing the plasma-derived volatiles in positive blood samples. These post-column fractions were collected at the exit of the GC according to their eluent times (i.e., 0–15 min, 15–25 min and 25–35 min or 0–35 min) and these full or fractional collections were presented to the trained dogs to judge their responses. Dogs' time spent investigating the odor was used as an indication of odor recognition and was significantly longer on the early (0–15 min) and middle (15–25 min) fractions of the ovarian cancer than the late (25–35 min) fraction of plasma odorants or either the negative fractions or distractors odorants. These findings suggest that characteristic odor biomarkers of ovarian cancer for dogs may exist in the relatively small and more volatile compounds. Additionally, variation between dogs suggests that there may be a number of different biomarkers that can be used to identify ovarian cancer. [Display omitted] •The outcome of the current study indicates that dogs can discriminate ovarian cancer VOC profiles from control and distractor VOC profiles.•Trained dogs do not seem to use one universal biomarker to discriminate ovarian cancer VOC profiles from those of control samples.•Dogs did not differentiate between the 25-35 minute fraction (heaviest volatiles) and the control plasma, suggesting that in general, the crucial biomarkers that define ovarian cancer are in the earlier eluted volatiles.